HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuron-specific enolase and S100B protein levels in recreational scuba divers with neurological decompression sickness.

AbstractINTRODUCTION:
Neuron-specific enolase (NSE) and S100B protein are brain-origin proteins commonly described to assess the presence and severity of neurological injury. To date, there are limited data examining the influence of scuba diving on these biomarkers, particularly when symptoms of decompression sickness (DCS) occur. The purpose of this controlled study was to determine whether these serum neurochemical markers could be used as 1) indicators of neurological DCS and 2) predictors of incomplete recovery.
METHODS:
Fifty-nine divers with neurological DCS and 37 asymptomatic divers admitted for inadequate decompression, serving as controls, were consecutively enrolled between 2010 and 2012. Blood samples were collected at initial presentation up to 6 hours after dive completion (controls) or onset of symptoms (DCS divers). Biomarkers were quantified in nonhaemolysed samples only. Clinical outcome was assessed at 6 months post-injury.
RESULTS:
The two groups did not differ regarding the variables examined, except for the total dive time which was slightly shorter in the control group. NSE, but not S100B protein, was higher in the DCS group than in controls (P < 0.0001). An NSE level > 15.9 µg L⁻¹ determined by ROC analysis predicted DCS development with a specificity of 100% (95% confidence interval (CI) 90 to 100) and a sensitivity of 24% (95% CI 14 to 36). There was a trend towards a higher likelihood of residual neurological deficits above this cut-off value (P = 0.08).
CONCLUSIONS:
Early determination of NSE was found to be useful for the diagnosis of neurological DCS with a high specificity. However, its clinical applicability in decision making for determining treatment as well as its prognostic value remains to be established. Reliability of S100B protein was not demonstrated in the present study.
AuthorsEmmanuel Gempp, Pierre Louge, Sébastien De Maistre, Loïc Emile, Jean-Eric Blatteau
JournalDiving and hyperbaric medicine (Diving Hyperb Med) Vol. 44 Issue 1 Pg. 26-9 (Mar 2014) ISSN: 1833-3516 [Print] Australia
PMID24687482 (Publication Type: Journal Article, Observational Study)
Chemical References
  • Biomarkers
  • S100 Calcium Binding Protein beta Subunit
  • S100B protein, human
  • Phosphopyruvate Hydratase
Topics
  • Biomarkers (blood)
  • Case-Control Studies
  • Decompression (methods)
  • Decompression Sickness (blood, enzymology)
  • Diving (adverse effects)
  • Female
  • High Pressure Neurological Syndrome (blood, enzymology)
  • Humans
  • Male
  • Middle Aged
  • Phosphopyruvate Hydratase (blood)
  • ROC Curve
  • Reference Values
  • Retrospective Studies
  • S100 Calcium Binding Protein beta Subunit (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: